News
08-17-2012, 04:22 AM
Eribulin was approved in March 2011 for women with locally advanced or metastasizing breast cancer in whom the disease has progressed despite prior drug therapy.
More... (http://www.news-medical.net/news/20120817/Study-examines-whether-eribulin-offers-added-benefit-to-women-with-breast-cancer.aspx)
More... (http://www.news-medical.net/news/20120817/Study-examines-whether-eribulin-offers-added-benefit-to-women-with-breast-cancer.aspx)